JLL to acquire pharmaceutical developer
The New York-based private equity firm will purchase the outstanding shares of PharmaNet Development Group for $5 a share in a deal valued at close to $100 million.
21 January 2013•1 min read
PRIVATE REAL ESTATE
Register to unlock this content
Daily global private real estate news and market intelligence- Expertly curated insights to keep you ahead of the market
- Faster, data-driven decision-making powered by our AI interface, Ask PEI
- Access to proprietary research and reports
- Selected investor strategy and competitor performance data